No Carolina / NY / Florida
Ph: 561.316.3330

Household Income and Health Insurance Among Factors in Decision to Withdraw Life Support After Hemorrhagic Stroke

Summation

  • Melmed, a clinical assistant professor in the Departments of Neurology and Neurosurgery at NYU Langone, says that while it has long been known that socioeconomic factors play a role in health and how well people recover, the role of these factors, beyond religion and race, have not until now been explored in detail for patients with intracerebral hemorrhages.
  • “Our study results highlight the many complex social, economic, religious, and racial factors that may play a role in decision making after a patient has suffered a severe bleed in the brain, or hemorrhagic stroke, and dies after withdrawal of life support,” said study lead investigator and neurologist Kara Melmed, MD.
  • Living in a high-income neighborhood, having private health insurance, and being older are tied to an increased likelihood that life support will be withdrawn for people who have suffered severe bleeding in the brain, a new study shows.

Decision to Withdraw Life Support After Hemorrhagic Stroke

Living in a high-income neighborhood, having private health insurance, and being older are tied to an increased likelihood that life support will be withdrawn for people who have suffered severe bleeding in the brain, a new study shows.

Social and Economic Factors

Led by researchers at NYU Grossman School of Medicine, the study focused on the social and economic factors linked to the withdrawal of life support and related death after being hospitalized for intracerebral hemorrhages. Such bleeds, sometimes referred to as hemorrhagic stroke, often lead to swelling in the brain, which can put a patient into a coma and frequently cause death.

Previous Studies

Previous studies had identified racial and religious disparities in death rates after such hemorrhages, with higher rates seen among Black and Hispanic patients and patients with deeply held religious beliefs.

Published Study

The study authors say their new work, published in the journal Neurology online Jan. 18, is important because it offers a better understanding of disparities that may help physicians to tailor end-of-life conversations with patients’ families, with the goal of removing age, racial, and economic disparities in health care.

Ischemic Stroke

Unlike ischemic stroke, which is caused by blocked blood vessels that can be cleared in many cases, hemorrhagic strokes are more often deadly. Some hemorrhagic stroke patients may undergo surgery to minimize the effects of swelling. In most cases, however, recovery is limited, and many patients need life-sustaining assistance with breathing and feeding. For these reasons, many patients and their families choose to withdraw life support.

Researchers Examined

For the new study, researchers examined the medical records of 868 patients admitted to three NYU Langone Health hospitals in Manhattan, Brooklyn, and Long Island for intracerebral hemorrhage from 2017 through 2022. Most were seniors and men of all races, with half relying on Medicare and one in five on Medicaid. While many survived their severe brain bleed and were discharged home or to a rehabilitation or nursing facility, 148 did not, and most of the decedents (84%) had had their life support, including ventilators and feeding tubes, withdrawn during their hospital stay.

Findings

The researchers found that hemorrhagic stroke patients living in city neighborhoods with higher incomes (i.e., above a yearly median of $88,687) were as much as 88% more likely to have life support withdrawn and to die subsequently than those living in poorer parts of the city (i.e., with yearly median incomes below $70,784). Being older than age 77 and on Medicare also heightened chances of having life support ended.

By contrast, being Black and having private insurance were factors tied to a lower likelihood of life support being withdrawn. Among hospitalized hemorrhagic stroke patients, Blacks made up 7% of those who had life support withdrawn but counted for 18% of those who maintained life support. Similarly, while 37% had private health insurance, only 20% of those who decided to withdraw life support had private insurance.

Religious Beliefs

Among the other study findings, Christians, especially Catholics, were 10% more likely to have life support withdrawn poststroke than maintained, and Jewish patients were 15% more likely to have life support maintained than withdrawn.

Conclusion

“Our study results highlight the many complex social, economic, religious, and racial factors that may play a role in decision making after a patient has suffered a severe bleed in the brain, or hemorrhagic stroke, and dies after withdrawal of life support,” said study lead investigator and neurologist Kara Melmed, MD.

Melmed, a clinical assistant professor in the Departments of Neurology and Neurosurgery at NYU Langone, says that while it has long been known that socioeconomic factors play a role in health and how well people recover, the role of these factors, beyond religion and race, have not until now been explored in detail for patients with intracerebral hemorrhages.

Further research is needed, the researchers say, because death is far more common in hemorrhagic stroke than in ischemic stroke.

Strokes of all kinds in the United States are not only a leading cause of death, but are also a health care disparity concern because strokes are twice as common in Blacks than in non-Blacks.

“Knowing that socioeconomic factors, especially income, play a role in hemorrhagic stroke outcomes is the first step in comprehending why these imbalances exist and how best to address them to make health care more equitable,” said senior study investigator and neurologist Jennifer Frontera, MD.

“Seeing any kind of disparity in health care is concerning,” said Frontera, a professor in the Department of Neurology at NYU Langone. “Clinicians in future may need to tailor end-of-life care discussions, taking into account cultural and social factors when treating patients who have suffered an intracerebral hemorrhage and, in particular, with respect to withdrawing life support.”

Besides Melmed and Frontera, other researchers at NYU Langone involved in this study, which was self-funded by the health system, are Ariane Lewis, MD; Lindsey Kuohn, MD; Joanna Marmo, BSN, RN, SCRN; Nirmala Rossan-Raghunath, MSN, SCRN; Jose Torres, MD; Rajanandini Muralidharan, MD; Aaron Lord, MD; and Koto Ishida, MD.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

New Inflammatory Bowel Disease Center Opens at Northwell Health

The new Inflammatory Bowel Disease Center, located at 125 Community Drive in Manhasset, has 13 exam rooms, two procedural rooms and six infusion bays. Since it started operations, people have travelled from all over the country – and as far away as Alaska – to receive high-quality care.

Cold Spring Harbor Laboratory and Northwell Health Extend Strategic Affiliation

“The alliance between Cold Spring Harbor Laboratory (CSHL) and Northwell Health brings transformative bioscience research into the clinic,” says CSHL President & CEO Bruce Stillman. “As New York’s largest healthcare provider, Northwell Health serves a remarkably diverse patient population. This agreement will provide patient communities with greater access to cutting-edge biomedical technology, allowing for more precise diagnoses and treatments, and ultimately facilitating new breakthroughs in cancer care.”

Hackensack Meridian Neuroscience Institute at JFK University Medical Center Receives $2.2 Million Research Grant to Study A Novel Traumatic Brain Injury Treatment

The NIH grant will fund a project entitled “Neutrophil Extracellular Traps And Associated Pathogenesis In TBI: A Novel Peptide Therapeutic Strategy” proposed by Mohammed Abdul Muneer, MSc, PhD, Research Scientist & Principal Investigator, Hackensack Meridian Neuroscience Institute at JFK University Medical Center, and Associate Professor of Neurology at the Hackensack Meridian School of Medicine.

By using this website you agree to accept Medical Device News Magazine Privacy Policy